22157.jpg
Global In Vitro Diagnostic eCommerce Business Report 2022: B2B/B2B2C Competitive Environment, Supply-Demand Pain Points, Strategies, and Use Cases
August 19, 2022 04:43 ET | Research and Markets
Dublin, Aug. 19, 2022 (GLOBE NEWSWIRE) -- The "In Vitro Diagnostic eCommerce Business Models Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. This study assesses...
22157.jpg
Virtual Clinical Trials Global Market Report 2022: Featuring Key Players ICON, Parexel International, IQVIA, Covance & PRA Health Sciences
August 16, 2022 08:13 ET | Research and Markets
Dublin, Aug. 16, 2022 (GLOBE NEWSWIRE) -- The "Virtual Clinical Trials Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global virtual clinical trials market...
PB Logo (1).png
Pardes Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
August 15, 2022 08:00 ET | Pardes Biosciences, Inc
CARLSBAD, Calif., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Pardes Biosciences, Inc. (NASDAQ: PRDS), a clinical-stage biopharmaceutical company developing PBI-0451 as a potential novel oral antiviral drug...
Hyris T-Cell Test finally allows healthcare specialists to depict SARS-CoV-2 specific immunity
Hyris' New T-Cell Test is Finally Available to EU Countries to Easily Map Patients' Cellular Immunity to SARS-CoV-2
August 05, 2022 08:00 ET | Hyris
LONDON, Aug. 05, 2022 (GLOBE NEWSWIRE) -- As the pandemic crisis has entered a new phase, it is a common belief among the scientific community that COVID-19 is here to stay, maybe for a long time....
Dyadic Logo Current.jpg
Dyadic to Report Second Quarter 2022 Financial Results on Wednesday, August 10, 2022
July 27, 2022 16:30 ET | Dyadic International, Inc.
JUPITER, Fla., July 27, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further...
Europe Cervical Cancer Screening Market
Europe Cervical Cancer Screening Market Report 2022: High Incidence Rate Driving Demand
July 08, 2022 06:38 ET | Research and Markets
Dublin, July 08, 2022 (GLOBE NEWSWIRE) -- The "Europe Cervical Cancer Screening Market, Forecast 2022-2027, Industry Trends, Share, Growth, Outlooks, Impact of COVID-19, Company Analysis" report has...
22157.jpg
Global Autoimmune Disease Diagnostics Market Report 2022: Rising Incidence of Autoimmune Diseases & Demand for Better and Accurate Diagnostic Procedure Fueling Growth
July 06, 2022 05:53 ET | Research and Markets
Dublin, July 06, 2022 (GLOBE NEWSWIRE) -- The "Global Autoimmune Disease Diagnostics Market (By Disease, Test Types, Region), Impact of COVID-19, Key Company Profiles, Recent Developments - Forecast...
22157.jpg
Global Liquid Biopsy Market Predicted to Surpass US$ 11 Billion by 2030
July 06, 2022 05:43 ET | Research and Markets
Dublin, July 06, 2022 (GLOBE NEWSWIRE) -- The "Global Liquid Biopsy Market, Impact of COVID-19, Initiatives, Funding, Major Deals, Company Profiles and Recent Developments - Forecast to 2030" report...
July 30, 2021 - ROSEN LOGO.jpg
YEXT SHAREHOLDER ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Yext, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – YEXT
July 03, 2022 20:45 ET | The Rosen Law Firm PA
NEW YORK, July 03, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Yext, Inc. (NYSE: YEXT) between March 4, 2021 and March 8,...
Pfizer and BioNTech
Pfizer and BioNTech Announce New Agreement with U.S. Government to Provide Additional Doses of COVID-19 Vaccine
June 29, 2022 16:45 ET | BioNTech SE
105 million 30 µg, 10 µg and 3 µg doses to be delivered into Q4 2022, with an option for the U.S. Government to purchase up to 195 million additional doses NEW YORK and MAINZ, GERMANY, JUNE...